Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 studyEfdoralprin alfa ...

Alpha-1 antitrypsin (AAT) deficiency is a genetic disease where your body doesn’t make enough normal functioning AAT. AAT is a protein your liver makes. AAT has many important roles in your body, ...

Study objectives: To propose an hypothesis that antiprotease augmentation therapy reduces the incidence of lung infections in a1-antitrypsin (AAT)-deficient patients, and to present supporting data.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with alpha-1 antitrypsin deficiency (AATD) ...

A new study presented at the 2013 American Thoracic Society International Conference suggests that using Alpha-1 proteinase inhibitor (A1-PI) to treat patients with Alpha-1 antitrypsin deficiency ...

Alpha-1 antitrypsin deficiency (AATD) is a genetic condition that may increase the risk of lung disease and other conditions. People with AATD lack the protective protein alpha-1 antitrypsin (AAT).

Sarah K. Brode, Simon C. Ling and Kenneth R. Chapman In this review, we highlight the pathogenesis, clinical features, diagnosis and treatment of alpha-1 antitrypsin deficiency. The evidence used in ...

LEXINGTON, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, ...

Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Alpha-1 Antitrypsin Deficiency Market - A Global and Regional Analysis: Focus on Treatment, Distribution Channel, and Regional Analysis - Analysis and ...

The Alpha 1 Antitrypsin Deficiency Treatment Market is a rapidly evolving sector within the healthcare industry, focused on developing and providing therapies for individuals affected by Alpha-1 ...

To get additional highlights on major revenue-generating segments, Request an alpha-1 antitrypsin deficiency augmentation therapy market sample report at https ...